Trial intelligence / Profile preview

Oliceridine vs fentanyl for postoperative analgesia and gastrointestinal function after thoracolumbar fusion

ChiCTR2500103999Phase 4Not yet recruiting

Sponsor
Nanjing Drum-Tower Hospital
Start
Jun 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of oliceridine in postoperative pain and thoracolumbar fusion (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: I-FEED score. Planned start Jun 2025; status: not yet recruiting.

02

Drugs

oliceridine
03

Conditions

postoperative painthoracolumbar fusion

Beyond the preview

Go deeper on ChiCTR2500103999.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500103999.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call